ZAP Surgical and Ibn Sina Medical Center Partner to Introduce Advanced Non-Invasive Brain Surgery to Africa

In a groundbreaking move, ZAP Surgical Systems and Ibn Sina Medical Center have joined forces to introduce the ZAP-X Gyroscopic Radiosurgery platform to Morocco, marking the first installation of this advanced technology in Africa. This partnership aims to revolutionize brain tumor treatment by offering a non-invasive, self-shielded system that eliminates the need for traditional radiation vaults and Cobalt-60 isotopes. The ZAP-X system’s innovative design allows for precise tumor targeting while minimizing exposure to healthy brain tissue, enhancing patient outcomes.

A New Era in Brain Tumor Treatment

The ZAP-X Gyroscopic Radiosurgery platform represents a significant advancement in the field of stereotactic radiosurgery (SRS). Unlike traditional SRS systems that require costly shielded treatment rooms and the use of radioactive isotopes, ZAP-X’s self-contained, self-shielded design simplifies the treatment process and reduces operational costs. This innovation makes advanced brain tumor treatments more accessible to hospitals and patients worldwide.

Secure patient data with ease. See how TrueNAS offers self-healing data protection.

Dr. Faouzi L’Habeeb, radiation and medical oncologist, managing partner, and chairman at Ibn Sina Medical Center, expressed enthusiasm about the partnership, stating, “The ZAP-X platform signifies the future of brain tumor treatment, allowing us to improve patients’ quality of life both throughout and following their treatment.” This sentiment underscores the transformative potential of the ZAP-X system in enhancing patient care.

Precision and Accessibility

One of the standout features of the ZAP-X system is its gyroscopic targeting capability, which enables radiosurgical beams to be delivered from thousands of potential angles. This precision allows clinicians to focus high-dose radiation on intracranial lesions while minimizing exposure to healthy brain tissue, thereby preserving cognitive function. Additionally, the system’s use of a modern linear accelerator to generate radiation eliminates the need for Cobalt-60 isotopes, addressing the logistical challenges associated with acquiring, securing, and replacing radioactive materials.

John R. Adler, MD, Professor Emeritus of Neurosurgery at Stanford University and Founder and CEO of ZAP Surgical Systems, highlighted the mission behind the technology: “ZAP Surgical’s mission is to make world-class stereotactic radiosurgery accessible to the millions of patients who currently lack access.” By reducing the costs and complexities of traditional SRS delivery, ZAP aims to support providers like Ibn Sina Medical Center in offering best-in-class care.

Expanding Global Reach

The collaboration between ZAP Surgical and Ibn Sina Medical Center is part of a broader strategy to expand the reach of the ZAP-X system globally. In recent years, ZAP Surgical has secured significant funding and partnerships to accelerate the manufacturing, sales, and distribution of the ZAP-X platform. Notably, in November 2024, the company closed a $78 million Series E funding round led by Qingdao Baheal Medical Inc., with participation from other strategic investors. This funding aims to advance the commercialization of the ZAP-X Gyroscopic Radiosurgery platform, furthering its mission to make advanced brain tumor treatments more accessible worldwide.

Looking Ahead

The installation of the ZAP-X system at Ibn Sina Medical Center in Casablanca is scheduled to begin in the summer of 2025, with patient treatments expected to start in early fall. This milestone not only signifies a leap forward in brain tumor treatment in Africa but also sets a precedent for the adoption of advanced medical technologies across the continent. As the healthcare landscape continues to evolve, partnerships like this one between ZAP Surgical and Ibn Sina Medical Center play a crucial role in bringing cutting-edge treatments to regions that have historically had limited access to such innovations.

References

• ZAP Surgical and Ibn Sina Medical Center to Bring Groundbreaking Non-Invasive Brain Surgery Platform to Africa. ZAP Surgical Systems. July 1, 2025. (zapsurgical.com)

• ZAP Surgical and Ibn Sina Medical Center Partner to Introduce Advanced Non-Invasive Brain Surgery to Africa. MedTech Spectrum. July 2, 2025. (medtechspectrum.com)

• ZAP Surgical Secures $78M in Series E Funding Led by Baheal Medical. ZAP Surgical Systems. November 8, 2024. (zapsurgical.com)

• ZAP Surgical and Ibn Sina Medical Center Partner to Introduce Advanced Non-Invasive Brain Surgery to Africa. MedTech Spectrum. July 3, 2025. (medtechspectrum.com)

• ZAP Surgical and Ibn Sina Medical Center Introduce Advanced Brain Surgery Platform in Africa. The Healthcare Technology Report. (thehealthcaretechnologyreport.com)

• ZAP Surgical Announces Strategic Partnership and Multi-System Order with Apollo Hospitals Enterprise Ltd. in India. Business Wire. March 1, 2022. (businesswire.com)

• ZAP Surgical nets $78m for radiosurgery platform. Medical Device Network. (medicaldevice-network.com)

• ZAP Surgical Announces Multi-System Order, Broadening Its Brain Tumor Treatment Footprint in the United Kingdom, Germany, and Spain. Business Wire. December 21, 2023. (businesswire.com)

• News and Press from ZAP Surgical. ZAP Surgical Systems. (zapsurgical.com)

• First ZAP-X Non-invasive Brain Tumor Treatment in South Asia. ZAP Surgical Systems. March 8, 2024. (zapsurgical.com)